33 related articles for article (PubMed ID: 11063624)
21. Neuropeptide Y2 receptors as drug targets for the central regulation of body weight.
Félétou M; Levens NR
Curr Opin Investig Drugs; 2005 Oct; 6(10):1002-11. PubMed ID: 16259221
[TBL] [Abstract][Full Text] [Related]
22. NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs?
Kamiji MM; Inui A
Curr Top Med Chem; 2007; 7(17):1734-42. PubMed ID: 17979782
[TBL] [Abstract][Full Text] [Related]
23. Structure-Activity Relationships of Pyrimidine Derivatives and their Biological Activity - A Review.
Natarajan R; Anthoni Samy HN; Sivaperuman A; Subramani A
Med Chem; 2022; 19(1):10-30. PubMed ID: 35579151
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.
Norman MH; Chen N; Chen Z; Fotsch C; Hale C; Han N; Hurt R; Jenkins T; Kincaid J; Liu L; Lu Y; Moreno O; Santora VJ; Sonnenberg JD; Karbon W
J Med Chem; 2000 Nov; 43(22):4288-312. PubMed ID: 11063624
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
Levens NR; Della-Zuana O
Curr Opin Investig Drugs; 2003 Oct; 4(10):1198-204. PubMed ID: 14649211
[TBL] [Abstract][Full Text] [Related]
26. NPY Y1 and Y5 receptor selective antagonists as anti-obesity drugs.
MacNeil DJ
Curr Top Med Chem; 2007; 7(17):1721-33. PubMed ID: 17979781
[TBL] [Abstract][Full Text] [Related]
27. Modulation of neuropeptide Y receptors for the treatment of obesity.
Sato N; Ogino Y; Mashiko S; Ando M
Expert Opin Ther Pat; 2009 Oct; 19(10):1401-15. PubMed ID: 19743896
[TBL] [Abstract][Full Text] [Related]
28. Appetite suppression based on selective inhibition of NPY receptors.
Chamorro S; Della-Zuana O; Fauchère JL; Félétou M; Galizzi JP; Levens N
Int J Obes Relat Metab Disord; 2002 Mar; 26(3):281-98. PubMed ID: 11896483
[TBL] [Abstract][Full Text] [Related]
29. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
Parker E; Van Heek M; Stamford A
Eur J Pharmacol; 2002 Apr; 440(2-3):173-87. PubMed ID: 12007534
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
